United Kingdom Prospective Diabetes Study: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page) |
imported>Robert Badgett No edit summary |
||
| Line 1: | Line 1: | ||
In [[health care]], the '''United Kingdom Prospective Diabetes Study''' ('''UKPDS''') is a [[randomized controlled trial]] of the treatment of [[diabetes mellitus type 2]].<ref name="pmid9742976">{{cite journal |author= |title=Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group |journal=Lancet |volume=352 |issue=9131 |pages=837–53 |year=1998 |pmid=9742976 |doi=10.1016/S0140-6736(98)07019-6}} [http://www.acpjc.org/Content/130/1/ISSUE/ACPJC-1999-130-1-002.htm Review by ACP Journal Club]</ref><ref name="pmid9742977">{{cite journal| author=| title=Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. | journal=Lancet | year= 1998 | volume= 352 | issue= 9131 | pages= 854-65 | pmid=9742977 | In [[health care]], the '''United Kingdom Prospective Diabetes Study''' ('''UKPDS''') is a [[randomized controlled trial]] of the treatment of [[diabetes mellitus type 2]].<ref name="pmid9742976">{{cite journal |author= |title=Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group |journal=Lancet |volume=352 |issue=9131 |pages=837–53 |year=1998 |pmid=9742976 |doi=10.1016/S0140-6736(98)07019-6}} [http://www.acpjc.org/Content/130/1/ISSUE/ACPJC-1999-130-1-002.htm Review by ACP Journal Club]</ref><ref name="pmid9742977">{{cite journal| author=| title=Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. | journal=Lancet | year= 1998 | volume= 352 | issue= 9131 | pages= 854-65 | pmid=9742977 | ||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=9742977 }}</ref> | | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=9742977 }}</ref> | ||
The UKPDS has created a [[clinical prediction rule]].<ref name="pmid11724655">{{cite journal| author=Stevens RJ, Kothari V, Adler AI, Stratton IM, United Kingdom Prospective Diabetes Study (UKPDS) Group| title=The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). | journal=Clin Sci (Lond) | year= 2001 | volume= 101 | issue= 6 | pages= 671-9 | pmid=11724655 | doi= | pmc= | url= }} </ref><ref>[http://www.dtu.ox.ac.uk/riskengine/ UKPDS Risk Engine]</ref> | |||
The study's website is at http://www.dtu.ox.ac.uk/ukpds_trial/. | The study's website is at http://www.dtu.ox.ac.uk/ukpds_trial/. | ||
Revision as of 05:20, 3 December 2010
In health care, the United Kingdom Prospective Diabetes Study (UKPDS) is a randomized controlled trial of the treatment of diabetes mellitus type 2.[1][2]
The UKPDS has created a clinical prediction rule.[3][4]
The study's website is at http://www.dtu.ox.ac.uk/ukpds_trial/.
references
- ↑ (1998) "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group". Lancet 352 (9131): 837–53. DOI:10.1016/S0140-6736(98)07019-6. PMID 9742976. Research Blogging. Review by ACP Journal Club
- ↑ (1998) "Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.". Lancet 352 (9131): 854-65. PMID 9742977.
- ↑ Stevens RJ, Kothari V, Adler AI, Stratton IM, United Kingdom Prospective Diabetes Study (UKPDS) Group (2001). "The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).". Clin Sci (Lond) 101 (6): 671-9. PMID 11724655. [e]
- ↑ UKPDS Risk Engine